Trial intelligence / Profile preview

Vitamin D Supplementation in PCOS

NCT01721915Phase 4Completed

Sponsor
Medical University of Graz
Start
Oct 2012
Primary completion
Oct 2017
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in polycystic ovary syndrome (PCOS) and Vitamin D deficiency (VDD) comparing Vitamin D supplementation with Placebo (2 arms). Primary endpoint: Area Under the Curve for Glucose at 24 weeks. Started Oct 2012; status: completed.

02

Drugs

vitamin d
03

Conditions

polycystic ovary syndrome (PCOS)Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT01721915.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01721915.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call